AlphaQuest LLC Has $204,000 Stake in Avantor, Inc. $AVTR

AlphaQuest LLC raised its stake in Avantor, Inc. (NYSE:AVTR) by 191.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,151 shares of the company’s stock after buying an additional 9,944 shares during the quarter. AlphaQuest LLC’s holdings in Avantor were worth $204,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Fifth Third Bancorp raised its position in shares of Avantor by 1,741.4% during the second quarter. Fifth Third Bancorp now owns 73,141 shares of the company’s stock worth $984,000 after purchasing an additional 69,169 shares during the period. Swedbank AB raised its position in shares of Avantor by 71.4% during the second quarter. Swedbank AB now owns 102,514 shares of the company’s stock worth $1,380,000 after purchasing an additional 42,700 shares during the period. Stanley Capital Management LLC raised its position in shares of Avantor by 42.9% during the first quarter. Stanley Capital Management LLC now owns 998,500 shares of the company’s stock worth $16,186,000 after purchasing an additional 300,000 shares during the period. Perpetual Ltd raised its position in shares of Avantor by 3.5% during the second quarter. Perpetual Ltd now owns 1,805,497 shares of the company’s stock worth $24,302,000 after purchasing an additional 60,823 shares during the period. Finally, US Bancorp DE raised its position in shares of Avantor by 85.5% during the first quarter. US Bancorp DE now owns 11,135 shares of the company’s stock worth $180,000 after purchasing an additional 5,133 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on AVTR shares. UBS Group set a $12.00 price target on Avantor in a research report on Thursday. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $12.00 price objective (down from $14.00) on shares of Avantor in a research report on Thursday. Jefferies Financial Group reaffirmed a “hold” rating on shares of Avantor in a research report on Friday, August 1st. Evercore ISI dropped their target price on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Thursday. Finally, Wells Fargo & Company dropped their target price on Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $14.42.

Avantor Stock Up 6.9%

AVTR stock opened at $11.82 on Monday. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $8.06 billion, a PE ratio of -90.89, a PEG ratio of 4.07 and a beta of 1.00. Avantor, Inc. has a 1-year low of $10.82 and a 1-year high of $23.70. The business’s 50 day simple moving average is $13.33 and its 200 day simple moving average is $13.24.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The firm’s revenue was down 5.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. As a group, research analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Buying and Selling at Avantor

In other Avantor news, Director Gregory L. Summe acquired 100,000 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was purchased at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the acquisition, the director directly owned 300,000 shares of the company’s stock, valued at approximately $3,375,000. This trade represents a 50.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Steven W. Eck sold 3,476 shares of the business’s stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at $627,224.52. This represents a 5.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.20% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.